Why the First Generic Drug Filer Gets 180 Days of Market Exclusivity

The first generic drug company to file a patent challenge gets 180 days of exclusive sales rights. This rule, from the Hatch-Waxman Act, was meant to speed up affordable drugs-but loopholes let some companies block competition without selling anything.

READ MORE